CRE research glossary

Claim review.

Claim review is the process of checking whether a displayed property, owner/entity, source, or recommendation reason is supported by reviewed records.

By Acren ResearchUpdated August 27, 2026
Short answer

Claim review is the process of checking whether a displayed property, owner/entity, source, or recommendation reason is supported by reviewed records.

How Acren uses claim review

Acren uses claim review to decide what can appear in an opportunity memo, what needs a confidence label, and what should remain an open question. It is a source-review process, not an investment recommendation.

Why it matters for CRE acquisition intelligence

Precise language makes an opportunity memo easier to review and harder to overread. The goal is to keep the first screen useful: what the record supports, what is still open, and which diligence step should happen next.

What this does not mean

In Acren, claim review does not predict seller intent, transaction intent, a valuation, a rent forecast, NOI, investment advice, or a recommendation to buy, sell, call, or pursue a property. It is part of the research record that helps decide what deserves the next step.

Example

A buyer can use this term to keep the first screen disciplined: identify the property, inspect the source trail, name the open questions, and route the next step.

Common mistakes

  • Using the term as a conclusion instead of a research label.
  • Skipping the next step after the opportunity memo surfaces.
FAQ

Is claim review a deal recommendation?

No. It helps explain or route a research lead. Comps, lease research, expenses, broker feedback, legal review, and underwriting remain separate diligence steps.

How should a buyer use this term?

Use it to keep the opportunity memo precise: what the record supports, what is still open, and who should review the next step.

Next step
Start with your market and buy box.

Responsible boundary. Not for FCRA-regulated use. Acren organizes commercial-property and business-entity records and ranks research priority from recorded evidence. It does not predict intent, provide valuation or underwriting, or support consumer-eligibility decisions.